Predictive value of co-existing genetic alterations and tumor mutation burden for patients with completely resected non-small cell lung cancer harboring EGFR mutation: Biomarker analysis of phase III IMPACT study

被引：0
|
作者：
Ikeda, Satoshi
Tsuboi, Masahiro
Sakai, Kazuko
Misumi, Toshihiro
Akamatsu, Hiroaki
Iwamoto, Yasuo
Sakakura, Noriaki
Nakamura, Atsushi
Ohde, Yasuhisa
Hayashi, Hidetoshi
Okishio, Kyoichi
Okada, Morihito
Yoshino, Ichiro
Okami, Jiro
Takahashi, Kazuhisa
Ikeda, Norihiko
Mitsudomi, Tetsuya
Tada, Hirohito
Nakagawa, Kazuhiko
Nishio, Kazuto
机构：
[1] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Kindai Univ, Fac Med, Osakasayama, Japan
[4] Natl Canc Ctr Hosp East, Dept Data Sci, Kashiwa, Chiba, Japan
[5] Wakayama Med Univ, Internal Med 3, Wakayama, Japan
[6] Hiroshima Citizens Hosp, Hiroshima, Japan
[7] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan
[8] Sendai Kousei Hosp, Sendai, Miyagi, Japan
[9] Shizuoka Canc Ctr, Shizuoka, Sunto Gun, Japan
[10] Natl Hosp Org Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[11] Hiroshima Univ, Hiroshima, Japan
[12] Chiba Univ, Grad Sch Med, Chiba, Japan
[13] Osaka Int Canc Inst, Osaka, Japan
[14] Juntendo Univ, Div Resp Med, Fac Med, Tokyo, Japan
[15] Grad Sch Med, Tokyo, Japan
[16] Tokyo Med Univ, Tokyo, Japan
[17] Suita Tokushukai Hosp, Suita, Osaka, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8524
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation
    Takahisa Kawamura
    Hirotsugu Kenmotsu
    Haruki Kobayashi
    Shota Omori
    Kazuhisa Nakashima
    Kazushige Wakuda
    Akira Ono
    Tateaki Naito
    Haruyasu Murakami
    Keita Mori
    Masahiro Endo
    Toshiaki Takahashi
    Investigational New Drugs, 2020, 38 : 194 - 201
  • [22] MUTATION ANALYSIS OF THE EGFR GENE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN XINJIANG
    Shi, Yi
    Pang, Xue-Lian
    Ma, Zhi-Ping
    Cui, Wen-Li
    Zhang, Wei
    Ma, Yu-Qing
    ACTA MEDICA MEDITERRANEA, 2021, 37 (06): : 3363 - 3368
  • [23] The Impact of EGFR Mutation Status on Outcomes in Patients With Resected Stage I Non-Small Cell Lung Cancers
    Izar, Benjamin
    Sequist, Lecia
    Lee, Mihan
    Muzikansky, Alona
    Heist, Rebecca
    Iafrate, John
    Dias-Santagata, Dora
    Mathisen, Douglas
    Lanuti, Michael
    ANNALS OF THORACIC SURGERY, 2013, 96 (03): : 962 - 968
  • [24] The Predictive Values of Advanced Non-Small Cell Lung Cancer Patients Harboring Uncommon EGFR Mutations-The Mutation Patterns, Use of Different Generations of EGFR-TKIs, and Concurrent Genetic Alterations
    Tan, Jiarong
    Hu, Chengping
    Deng, Pengbo
    Wan, Rongjun
    Cao, Liming
    Li, Min
    Yang, Huaping
    Gu, Qihua
    An, Jian
    Jiang, Juan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    J. Chantharasamee
    N. Poungvarin
    P. Danchaivijitr
    S. Techawatanawanna
    BMC Cancer, 19
  • [26] Clinical outcome of treatment of metastatic non-small cell lung cancer in patients harboring uncommon EGFR mutation
    Chantharasamee, J.
    Poungvarin, N.
    Danchaivijitr, P.
    Techawatanawanna, S.
    BMC CANCER, 2019, 19 (1)
  • [27] The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.
    Tu, Haiyan
    Ke, Ee
    Sun, Yue-Li
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Wang, Zhen
    Wu, Si-Pei
    Su, Jian
    Zhang, Xuchao
    Bai, Xiao-Yan
    Yang, Xue-Ning
    Zhong, Wenzhao
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Integrated chemotherapy with EGFR receptor tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutation
    Maevskaya, J.
    Laktionov, K.
    Yudin, D.
    Vladimirova, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S1402 - S1402
  • [29] Driven by by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non-Small Cell Lung Cancer
    Castellanos, Emily
    Feld, Emily
    Horn, Leora
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (04) : 612 - 623
  • [30] VALUE OF EGFR GENE MUTATION ANALYSIS IN CHINESE NON SMALL CELL LUNG CANCER PATIENTS
    Sun, M.
    Shen, L.
    Cai, X.
    Chen, H.
    Du, X.
    Zhou, X.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S44 - S44
12345